Login / Signup
Fang Li
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 1
Top Topics
Free Survival
Neoadjuvant Chemotherapy
Drug Administration
Phase Iii
Top Venues
Clinical cancer research : an official journal of the American Association for Cancer Research
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Michael H Brave
,
William F Maguire
,
Chana Weinstock
,
Hui Zhang
,
Xin Gao
,
Fang Li
,
Jingyu Yu
,
Wentao Fu
,
Hong Zhao
,
William F Pierce
,
Elaine Chang
,
Jeannette Dinin
,
Mallorie H Fiero
,
Nam Atiqur Rahman
,
Shenghui Tang
,
Richard Pazdur
,
Paul G Kluetz
,
Laleh Amiri-Kordestani
,
Daniel L Suzman
FDA Approval Summary: Enfortumab Vedotin Plus Pembrolizumab for Locally Advanced or Metastatic Urothelial Carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research
(2024)